Home > Insider Trading > Portola Pharmaceuticals Inc

Portola Pharmaceuticals Inc (PTLA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

Bristol-Myers Squibb Co (BMY) And Pfizer Inc. (PFE) Agree To $50 Million Loan To Portola Pharmaceuticals Inc (PTLA)

There is a need for additional funding towards the development and clinical studies of AndexXa, a new compound that is a prospective antidote for Factor Xa inhibitors.

Keep Reading →

December 20th, 2016 - News Stock Analysis

Is Portola Pharmaceuticals Inc (PTLA) Worthy of Your Portfolio?

Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us with significant...

Keep Reading →

December 6th, 2016 - Hedge Funds News

Here's Why Smart Money Investors Are Betting on Portola Pharmaceuticals

Portola Pharmaceuticals Inc (NASDAQ:PTLA) is a $1.17 billion biopharmaceutical company and potential takeover candidate that develops and commercializes therapeutics for patients in the areas of thrombosis...

Keep Reading →

August 31st, 2016 - News Stock Analysis

Portola Pharmaceuticals Inc (PTLA): A Misinterpretation Discount?

Portola Pharmaceuticals Inc (NASDAQ:PTLA) has held a conference call to discuss its latest earnings, and on the call, reiterated its intentions to submit a new drug application (NDA) to the FDA in an...

Keep Reading →

August 18th, 2016 - News Stock Analysis

Two Under The Radar Biotech Decisions To Watch Next Month

On August 15, the FDA will serve up its judgment on a supplemental new biologics application (sNDA) for Emergent Biosolutions Inc (NYSE:EBS)’s BioThrax.

Keep Reading →

July 25th, 2016 - News Stock Analysis

Portola Pharmaceuticals Inc (PTLA): This Hedge Fund is Loading Up Following Stock's Weakness

It's been a disastrous year for Portola Pharmaceuticals Inc (NASDAQ:PTLA) thus far, as the company has shed over 60% of its value year-to-date.

Keep Reading →

March 30th, 2016 - Hedge Funds News

Why These Stocks Are Trading In Red Today

The US Stock Market is quite flattish on Monday, with major indexes posting small gains.

Keep Reading →

March 28th, 2016 - Market Movers News

PayPal, Portola Pharmaceuticals, Antero Midstream, Lannett and California Resources Are All Down Today: Here's Why

Oil continues to tumble on Thursday, driven by a strengthening dollar and record high stockpiles in the U.S, pushing the commodity back below the $40 a barrel threshold.

Keep Reading →

March 24th, 2016 - Market Movers News